Inhibition of angiogenesis by a Semliki Forest virus vector expressing VEGFR-2 reduces tumour growth and metastasis in mice. (Q44352273)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17167497%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

title

Inhibition of angiogenesis by a Semliki Forest virus vector expressing VEGFR-2 reduces tumour growth and metastasis in mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17167497%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

0 references

0 references

Sareen Elizabeth Galbraith

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17167497%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Brian J. Sheahan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17167497%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

Lyons JA

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17167497%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Mehra R

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17167497%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Atkins GJ

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17167497%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Fleeton MN

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17167497%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

14 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17167497%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17167497%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17167497%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17167497%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

503-513

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17167497%20AND%20SRC:MED&resulttype=core&format=json

Role of angiogenesis in tumor growth and metastasis

23 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

Angiogenesis as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

Antiangiogenic tumour therapy: will it work?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

Genes expressed in human tumor endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

Combined effects of angiostatin and ionizing radiation in antitumour therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

Blood vessel formation: what is its molecular basis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

VEGF: an update on biological and therapeutic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

Antiangiogenic and antivascular therapy for cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

Vaccines targeting tumour angiogenesis--a novel strategy for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

Active immunization against the vascular endothelial growth factor receptor flk1 inhibits tumor angiogenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

T cell-mediated suppression of angiogenesis results in tumor protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

Effect of intranasal administration of Semliki Forest virus recombinant particles expressing reporter and cytokine genes on the progression of experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

Regression of mouse tumours and inhibition of metastases following administration of a Semliki Forest virus vector with enhanced expression of IL-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

Semliki forest virus vectors engineered to express higher IL-12 levels induce efficient elimination of murine colon adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

Immunotherapy with recombinant SFV-replicons expressing the P815A tumor antigen or IL-12 induces tumor regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

The lineage decisions of helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

Enhanced antimetastatic effect of fetal liver kinase 1 extracellular domain and interferon-gamma fusion gene-modified dendritic cell vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

Combined therapy with flk1-based DNA vaccine and interleukin-12 results in enhanced antiangiogenic and antitumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

Vaccination with recombinant alphavirus or immune-stimulating complex antigen against respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

Tumor antigen-specific T helper cells in cancer immunity and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

Treatment of rapidly growing K-BALB and CT26 mouse tumours using Semliki Forest virus and its derived vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

Synergy between tumor immunotherapy and antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

7 January 2021

Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

7 January 2021

Rationale for antiangiogenic cancer therapy with vaccination using epitope peptides derived from human vascular endothelial growth factor receptor 2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

7 January 2021

Two-helper RNA system for production of recombinant Semliki forest virus particles.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

7 January 2021

Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302889

7 January 2021